凯信远达(CASI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CASI 凯信远达

已收盘 07-11 16:00:00 EDT

1.40

-0.03

-2.10%

盘后1.33

-0.07-5.00%

16:59 EDT

最高1.43	最低1.32	成交量2.65万
今开1.41	昨收1.43	日振幅7.69%
总市值2,169万	流通市值860.48万	总股本1,549万
成交额3.66万	换手率0.43%	流通股本614.63万
市净率-2.69	ROE-1094.50%	每股收益-2.55
52周最高7.67	52周最低1.09	市盈率-0.55
股息0.00	股息收益率0.00	ROA-50.88%

北京优虎网络科技有限公司

{"stockData":{"symbol":"CASI","market":"US","secType":"STK","nameCN":"凯信远达","latestPrice":1.4,"timestamp":1752264000000,"preClose":1.43,"halted":0,"volume":26505,"hourTrading":{"tag":"盘后","latestPrice":1.33,"preClose":1.4,"latestTime":"16:59 EDT","volume":5875,"amount":7652.28,"timestamp":1752267572764},"delay":0,"floatShares":6146256,"shares":15492681,"eps":-2.551883,"marketStatus":"已收盘","change":-0.03,"latestTime":"07-11 16:00:00 EDT","open":1.41,"high":1.43,"low":1.32,"amount":36594.6663015,"amplitude":0.076923,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.551883,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":834552000000,"exchange":"NASDAQ","adjPreClose":1.43,"preHourTrading":{"tag":"盘前","latestPrice":1.4,"preClose":1.43,"latestTime":"08:59 EDT","volume":750,"amount":1052.000025,"timestamp":1752238753059},"postHourTrading":{"tag":"盘后","latestPrice":1.33,"preClose":1.4,"latestTime":"16:59 EDT","volume":5875,"amount":7652.28,"timestamp":1752267572764},"volumeRatio":0.893905,"impliedVol":0.9131,"impliedVolPercentile":0.464},"requestUrl":"/m/hq/s/CASI","defaultTab":"news","newsList":[{"id":"2550603243","title":"凯信远达7月10日成交额为2.57万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550603243","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550603243?lang=zh_cn&edition=full","pubTime":"2025-07-11 09:28","pubTimestamp":1752197324,"startTime":"0","endTime":"0","summary":"美东时间2025年7月10日，凯信远达成交额为2.57万美元，成交额较昨日减少18.52%，当日成交量为1.84万股。凯信远达于2025年7月10日涨1.42%，报1.43美元，该股过去5个交易日涨7.52%，年初至今跌49.47%，过去60日跌26.67%。这些产品包括为患有白血病和淋巴瘤的患者注射。迈维宁注射液用作多发性骨髓瘤患者自体干细胞移植前的预处理治疗。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711092851a443901b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711092851a443901b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2550087650","title":"凯信远达盘中异动 下午盘快速下跌6.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550087650","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550087650?lang=zh_cn&edition=full","pubTime":"2025-07-10 03:18","pubTimestamp":1752088683,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日03时18分，凯信远达股票出现异动，股价急速下挫6.05%。截至发稿，该股报1.32美元/股，成交量1.9957万股，换手率0.13%，振幅9.25%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。凯信远达股票所在的生物技术行业中，整体涨幅为1.42%。这些产品包括为患有白血病和淋巴瘤的患者注射。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710031803979ffe16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710031803979ffe16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2549530031","title":"凯信远达盘中异动 早盘大幅下跌5.38%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549530031","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549530031?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:43","pubTimestamp":1751895832,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时43分，凯信远达股票出现异动，股价大幅下跌5.38%。截至发稿，该股报1.23美元/股，成交量2807股，换手率0.02%，振幅0.00%。凯信远达股票所在的生物技术行业中，整体跌幅为0.60%。这些产品包括为患有白血病和淋巴瘤的患者注射。迈维宁注射液用作多发性骨髓瘤患者自体干细胞移植前的预处理治疗。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707214353a43bfb61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707214353a43bfb61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2548883130","title":"凯信远达盘中异动 快速拉升6.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548883130","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548883130?lang=zh_cn&edition=full","pubTime":"2025-07-01 23:08","pubTimestamp":1751382507,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日23时08分，凯信远达股票出现波动，股价大幅拉升6.50%。截至发稿，该股报1.26美元/股，成交量4110股，换手率0.03%，振幅3.39%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。凯信远达股票所在的生物技术行业中，整体涨幅为0.55%。这些产品包括为患有白血病和淋巴瘤的患者注射。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701230828a4c93f6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701230828a4c93f6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2547090691","title":"凯信远达盘中异动 早盘急速下挫5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547090691","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547090691?lang=zh_cn&edition=full","pubTime":"2025-06-30 21:34","pubTimestamp":1751290475,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时34分，凯信远达股票出现异动，股价大幅下挫5.17%。截至发稿，该股报1.14美元/股，成交量8927股，换手率0.06%，振幅3.33%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。凯信远达股票所在的生物技术行业中，整体涨幅为0.21%。这些产品包括为患有白血病和淋巴瘤的患者注射。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213435a726447c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213435a726447c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2546789357","title":"凯信远达6月27日成交额为3.79万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546789357","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546789357?lang=zh_cn&edition=full","pubTime":"2025-06-28 09:27","pubTimestamp":1751074020,"startTime":"0","endTime":"0","summary":"美东时间2025年6月27日，凯信远达成交额为3.79万美元，成交额较昨日减少24.64%，当日成交量为3.06万股。凯信远达于2025年6月27日跌7.69%，报1.2美元，该股过去5个交易日跌9.77%，年初至今跌57.6%，过去60日跌42.86%。这些产品包括为患有白血病和淋巴瘤的患者注射。迈维宁注射液用作多发性骨髓瘤患者自体干细胞移植前的预处理治疗。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628092708a4c23373&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628092708a4c23373&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2546876509","title":"凯信远达6月26日成交额为5.04万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546876509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546876509?lang=zh_cn&edition=full","pubTime":"2025-06-27 09:26","pubTimestamp":1750987614,"startTime":"0","endTime":"0","summary":"美东时间2025年6月26日，凯信远达成交额为5.04万美元，成交额较昨日增加37.61%，当日成交量为3.94万股。凯信远达于2025年6月26日涨0.39%，报1.3美元，该股过去5个交易日跌4.41%，年初至今跌54.06%，过去60日跌39.81%。这些产品包括为患有白血病和淋巴瘤的患者注射。迈维宁注射液用作多发性骨髓瘤患者自体干细胞移植前的预处理治疗。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627092704a4c00574&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627092704a4c00574&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2546240023","title":"凯信远达盘中异动 下午盘快速跳水5.55%报1.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546240023","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546240023?lang=zh_cn&edition=full","pubTime":"2025-06-26 01:58","pubTimestamp":1750874337,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日01时58分，凯信远达股票出现波动，股价快速下挫5.55%。截至发稿，该股报1.27美元/股，成交量2.4124万股，换手率0.16%，振幅5.20%。凯信远达股票所在的生物技术行业中，整体跌幅为0.77%。这些产品包括为患有白血病和淋巴瘤的患者注射。迈维宁注射液用作多发性骨髓瘤患者自体干细胞移植前的预处理治疗。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626015857a4bdc10d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626015857a4bdc10d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2545268233","title":"凯信远达盘中异动 快速上涨7.32%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545268233","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545268233?lang=zh_cn&edition=full","pubTime":"2025-06-24 21:50","pubTimestamp":1750773040,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日21时50分，凯信远达股票出现异动，股价大幅上涨7.32%。截至发稿，该股报1.32美元/股，成交量2.1957万股，换手率0.14%，振幅14.72%。凯信远达股票所在的生物技术行业中，整体涨幅为0.58%。这些产品包括为患有白血病和淋巴瘤的患者注射。迈维宁注射液用作多发性骨髓瘤患者自体干细胞移植前的预处理治疗。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624215040a4bb9d38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624215040a4bb9d38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2545541011","title":"凯信远达盘中异动 早盘快速下挫6.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545541011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545541011?lang=zh_cn&edition=full","pubTime":"2025-06-23 21:44","pubTimestamp":1750686284,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日21时44分，凯信远达股票出现异动，股价快速下跌6.29%。截至发稿，该股报1.24美元/股，成交量1.8743万股，换手率0.12%，振幅4.15%。凯信远达股票所在的生物技术行业中，整体涨幅为0.29%。凯信远达公司简介：凯信远达医药公司是一家专注于治疗和医药产品商业化的生物制药公司。这些产品包括为患有白血病和淋巴瘤的患者注射。迈维宁注射液用作多发性骨髓瘤患者自体干细胞移植前的预处理治疗。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623214444a4b92b19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623214444a4b92b19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2544173417","title":"凯信远达上涨7.76%，报1.466美元/股，总市值2270.45万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544173417","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544173417?lang=zh_cn&edition=full","pubTime":"2025-06-20 22:04","pubTimestamp":1750428279,"startTime":"0","endTime":"0","summary":"6月20日，凯信远达盘中上涨7.76%，截至22:04，报1.466美元/股，成交2.28万美元，总市值2270.45万美元。财务数据显示，截至2025年03月31日，凯信远达收入总额624.0万美元，同比增长83.04%；归母净利润-1075.0万美元，同比减少12.83%。资料显示，凯信远达医药公司是一家美国纳斯达克上市的生物医药公司,致力于在血液肿瘤领域为中国患者提供先进的疾病治疗方案。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/20220451211950.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2544187614","title":"凯信远达6月18日成交额为34.19万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544187614","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544187614?lang=zh_cn&edition=full","pubTime":"2025-06-19 09:28","pubTimestamp":1750296485,"startTime":"0","endTime":"0","summary":"美东时间2025年6月18日，凯信远达成交额为34.19万美元，成交额较昨日减少74.93%，当日成交量为24.10万股。凯信远达于2025年6月18日跌7.48%，报1.36美元，该股过去5个交易日跌25.68%，年初至今跌51.94%，过去60日跌35.85%。这些产品包括为患有白血病和淋巴瘤的患者注射。迈维宁注射液用作多发性骨髓瘤患者自体干细胞移植前的预处理治疗。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619092815a7117e95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619092815a7117e95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2544994397","title":"凯信远达上涨23.06%，报1.637美元/股，总市值2535.69万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544994397","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544994397?lang=zh_cn&edition=full","pubTime":"2025-06-18 00:50","pubTimestamp":1750179048,"startTime":"0","endTime":"0","summary":"6月18日，凯信远达盘中上涨23.06%，截至00:50，报1.637美元/股，成交22.53万美元，总市值2535.69万美元。财务数据显示，截至2025年03月31日，凯信远达收入总额624.0万美元，同比增长83.04%；归母净利润-1075.0万美元，同比减少12.83%。资料显示，凯信远达医药公司是一家美国纳斯达克上市的生物医药公司,致力于在血液肿瘤领域为中国患者提供先进的疾病治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/18005051130861.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2543603298","title":"凯信远达盘中异动 股价大跌5.43%报1.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543603298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543603298?lang=zh_cn&edition=full","pubTime":"2025-06-16 21:47","pubTimestamp":1750081679,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日21时47分，凯信远达股票出现波动，股价大幅下挫5.43%。截至发稿，该股报1.74美元/股，成交量3.0168万股，换手率0.19%，振幅8.15%。凯信远达股票所在的生物技术行业中，整体跌幅为0.19%。这些产品包括为患有白血病和淋巴瘤的患者注射。迈维宁注射液用作多发性骨髓瘤患者自体干细胞移植前的预处理治疗。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616214800951ec718&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616214800951ec718&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2543454633","title":"凯信远达盘中异动 股价大涨5.59%报1.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543454633","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543454633?lang=zh_cn&edition=full","pubTime":"2025-06-13 22:22","pubTimestamp":1749824565,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日22时22分，凯信远达股票出现波动，股价大幅拉升5.59%。截至发稿，该股报1.89美元/股，成交量1.3628万股，换手率0.09%，振幅7.74%。凯信远达股票所在的生物技术行业中，整体跌幅为0.59%。这些产品包括为患有白血病和淋巴瘤的患者注射。迈维宁注射液用作多发性骨髓瘤患者自体干细胞移植前的预处理治疗。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613222246977e5603&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613222246977e5603&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2542424083","title":"凯信远达盘中异动 快速下挫6.95%报1.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542424083","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542424083?lang=zh_cn&edition=full","pubTime":"2025-06-11 03:29","pubTimestamp":1749583741,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日03时29分，凯信远达股票出现波动，股价急速下挫6.95%。截至发稿，该股报1.74美元/股，成交量1.7148万股，换手率0.11%，振幅6.95%。凯信远达股票所在的生物技术行业中，整体涨幅为1.00%。这些产品包括为患有白血病和淋巴瘤的患者注射。迈维宁注射液用作多发性骨髓瘤患者自体干细胞移植前的预处理治疗。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611032901a4a257ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611032901a4a257ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2540772208","title":"凯信远达盘中异动 股价大涨8.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540772208","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540772208?lang=zh_cn&edition=full","pubTime":"2025-06-03 21:38","pubTimestamp":1748957927,"startTime":"0","endTime":"0","summary":"北京时间2025年06月03日21时38分，凯信远达股票出现异动，股价大幅上涨8.24%。截至发稿，该股报2.00美元/股，成交量1016股，换手率0.01%，振幅0.00%。凯信远达股票所在的生物技术行业中，整体跌幅为0.18%。凯信远达公司简介：凯信远达医药公司是一家专注于治疗和医药产品商业化的生物制药公司。这些产品包括为患有白血病和淋巴瘤的患者注射。迈维宁注射液用作多发性骨髓瘤患者自体干细胞移植前的预处理治疗。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603213847a498609c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603213847a498609c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2538649507","title":"凯信远达盘中异动 下午盘大幅下跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2538649507","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538649507?lang=zh_cn&edition=full","pubTime":"2025-05-28 01:09","pubTimestamp":1748365753,"startTime":"0","endTime":"0","summary":"北京时间2025年05月28日01时09分，凯信远达股票出现波动，股价快速下跌5.21%。截至发稿，该股报1.77美元/股，成交量2174股，换手率0.01%，振幅1.87%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。凯信远达股票所在的生物技术行业中，整体涨幅为1.29%。这些产品包括为患有白血病和淋巴瘤的患者注射。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528010914a48ea59e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528010914a48ea59e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2536346239","title":"凯信远达上涨8.83%，报1.97美元/股，总市值3051.90万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536346239","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536346239?lang=zh_cn&edition=full","pubTime":"2025-05-17 01:22","pubTimestamp":1747416175,"startTime":"0","endTime":"0","summary":"5月17日，凯信远达盘中上涨8.83%，截至01:22，报1.97美元/股，成交4690.0美元，总市值3051.90万美元。财务数据显示，截至2024年12月31日，凯信远达收入总额2853.7万美元，同比减少15.77%；归母净利润-3925.8万美元，同比减少45.73%。资料显示，凯信远达医药公司是一家美国纳斯达克上市的生物医药公司,致力于在血液肿瘤领域为中国患者提供先进的疾病治疗方案。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/17012250465675.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2536349960","title":"凯信远达盘中异动 下午盘股价大涨8.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536349960","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536349960?lang=zh_cn&edition=full","pubTime":"2025-05-17 01:22","pubTimestamp":1747416152,"startTime":"0","endTime":"0","summary":"北京时间2025年05月17日01时22分，凯信远达股票出现异动，股价急速上涨8.83%。截至发稿，该股报1.97美元/股，成交量1873股，换手率0.01%，振幅0.00%。凯信远达股票所在的生物技术行业中，整体涨幅为0.52%。凯信远达公司简介：凯信远达医药公司是一家专注于治疗和医药产品商业化的生物制药公司。这些产品包括为患有白血病和淋巴瘤的患者注射。迈维宁注射液用作多发性骨髓瘤患者自体干细胞移植前的预处理治疗。大部分收入来自迈维宁的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517012233aa2c91b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517012233aa2c91b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.casipharmaceuticals.com","stockEarnings":[{"period":"1week","weight":0.1},{"period":"1month","weight":-0.2353},{"period":"3month","weight":-0.2667},{"period":"6month","weight":-0.4521},{"period":"1year","weight":-0.7807},{"period":"ytd","weight":-0.4947}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":0.0377},{"period":"3month","weight":0.1721},{"period":"6month","weight":0.0781},{"period":"1year","weight":0.1149},{"period":"ytd","weight":0.0678}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"凯信远达医药公司于1991年注册成立，是一家在开曼群岛注册成立的豁免公司。该公司是一家生物制药公司，专注于在中国、美国和世界各地开发和商业化创新疗法和医药产品。公司打造了一家完全一体化、世界一流的生物制药公司，致力于创新和其他治疗产品的成功开发和商业化。公司业务发展战略目前的重点是通过许可获得额外的靶向药物和免疫肿瘤疗法，这将扩大血液学/肿瘤学特许经营权。","yearOnYearQuotes":[{"month":1,"riseRate":0.689655,"avgChangeRate":0.165398},{"month":2,"riseRate":0.344828,"avgChangeRate":-0.010081},{"month":3,"riseRate":0.310345,"avgChangeRate":-0.000942},{"month":4,"riseRate":0.37931,"avgChangeRate":0.030827},{"month":5,"riseRate":0.241379,"avgChangeRate":0.04909},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.032316},{"month":7,"riseRate":0.266667,"avgChangeRate":-0.051927},{"month":8,"riseRate":0.310345,"avgChangeRate":-0.030773},{"month":9,"riseRate":0.482759,"avgChangeRate":0.008222},{"month":10,"riseRate":0.62069,"avgChangeRate":0.096357},{"month":11,"riseRate":0.37931,"avgChangeRate":0.031415},{"month":12,"riseRate":0.241379,"avgChangeRate":-0.098457}],"exchange":"NASDAQ","name":"凯信远达","nameEN":"CASI Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯信远达(CASI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯信远达(CASI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯信远达,CASI,凯信远达股票,凯信远达股票老虎,凯信远达股票老虎国际,凯信远达行情,凯信远达股票行情,凯信远达股价,凯信远达股市,凯信远达股票价格,凯信远达股票交易,凯信远达股票购买,凯信远达股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯信远达(CASI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯信远达(CASI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}